SPEED TO MARKET: A qualified CDMO can help drug companies accelerate their timelines to market, which can be especially important in highly competitive markets. • SGS Quay Pharma has the experience and resources to help companies bring their products to market quickly with our comprehensive service offering from formulation to manufacturing, as well as our access to specialized expertise, state-of-the-art equipment and deep regulatory knowledge.
for a client to endure the process of commissioning and qualifying both the necessary facilities and equipment. This also delivers considerable risk mitigation as the usual sizable upfront investment at the early stages of drug development is not required. REDUCED REGULATORY BURDEN: The regulatory landscape is constantly changing with new regulations and increasing complexities. An experienced CDMO can support a company by navigating the complex regulatory landscape associated with drug development and manufacturing. • SGS Quay Pharma continuously monitors the regulatory landscape and is actively involved in industry groups, forums and regulatory committees that drive and define these regulations. With this knowledge and insight, our team can assist clients in understanding and implementing any changes in regulations that may impact their products.
04
Made with FlippingBook Ebook Creator